Study suggests promising potential of Pomanox® pomegranate extract for eye health
In a recent publication in the Journal of Clinical and Translational Ophthalmology, researchers examined the anti-inflammatory effects of Euromed’s Pomanox® using a cell model to test eye damage. The study focused on evaluating Pomanox®’s anti-inflammatory potential on cytokine secretion activity using a model of reconstituted human corneal epithelial cells. Results showed significant reduction in the production of interleukin-8 (IL-8), a key inflammatory cytokine, when the cells were exposed to bacterial material. The findings indicate that Pomanox® is a promising candidate for addressing ocular inflammation, with potential eye health benefits.